Skip to content

The Systematic Medical Appraisal, Referral and Treatment (SMART) Mental Health Programme

The Systematic Medical Appraisal, Referral and Treatment(SMART) Mental Health Programme - SMART

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015355
Enrollment
165000
Registered
2018-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Mental Health Health Condition 2: F068- Other specified mental disorders due to known physiological condition

Interventions

Intervention1: Anti Stigma and mhealth: (1) the anti-stigma campaign to increase awareness of CMDs in the community
and (2) implementation of the enhanced mobile technology based decision support system for people identified at high risk of CMDs. Component 1- Stigma reduction campaign for general population: The c

Sponsors

The George Institute For Global Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consenting adults >= 18 years of age

Exclusion criteria

Exclusion criteria: Physical ill-health or any severe health condition that would prevent regular follow-up

Design outcomes

Primary

MeasureTime frame
To assess the mHealth/ task sharing component the mean difference in PHQ-9 scores at end of trial will be assessed in theâ??high-riskâ?? cohort. To evaluate the anti-stigma intervention â?? the difference in mean behaviour scores at end of trial using the Mental Health Knowledge, Attitude and Behaviour (KAB) scale will be analysed in both combined â??highriskâ?? and â??non-high-riskâ?? cohort and separately within the groups.Timepoint: 12 months

Secondary

MeasureTime frame
To assess the mHealth/ task sharing component the difference at end of trial in the proportion of people achieving remission (defined as all three of the following: PHQ-9 5, GAD-7 5 and suicide risk score 2) in the â??high-riskâ?? cohort. Mean difference in GAD-7 scores in the â??high riskâ?? cohort Mean difference in PHQ9/ GAD7 scores at 6 months Timepoint: 12 months

Countries

India

Contacts

Public ContactDr Pallab Maulik

George Institute For Global health

pmaulik@georgeinstitute.org.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 9, 2026